Loren Data's SAM Daily™

FBO DAILY ISSUE OF DECEMBER 11, 2009 FBO #2939
SOLICITATION NOTICE

76 -- Online Electronic Web Access to Natural Medicines Comprehensive database or Equal to Product

Notice Date

12/9/2009
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

511120 — Periodical Publishers
 

Contracting Office

Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
 

ZIP Code

20857-0001
 

Solicitation Number

FDA-SOL-10-1067592
 

Archive Date

1/1/2010
 

Point of Contact

Brendan McCarthy, Phone: 3018274680, Sherry Solodkova, Phone: 301-827-7165
 

E-Mail Address

Brendan.McCarthy@fda.hhs.gov, sherry.solodkova@fda.hhs.gov
(Brendan.McCarthy@fda.hhs.gov, sherry.solodkova@fda.hhs.gov)
 

Small Business Set-Aside

N/A
 

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This synopsis is to notify contractors that the government intends to issue a Purchase Order on a brand name or equal basis in accordance with FAR Part 13 for the following, under simplified acquisition procedures. The Request for Proposal number is FDA-SOL-10-1067592. Provisions and clauses in effect through Federal Acquisition Circular 05-37 are incorporated into this request. It is the contractor’s responsibility to be familiar with the applicable clauses and provisions. The provisions and clauses may be accessed in full text at www.acquisition.gov/far. The NAICS code is 511120 Periodical Publishers, with a small business size of 500 employees. There is no set-aside for this acquisition. All qualified vendors are encouraged to submit a proposal. The purpose of this procurement is to establish a contract for eight (8) concurrent user to access the Natural Medicines Comprehensive database (brand name or equal to product) for one (1) base year and three (3) additional one year option years. Products shall support the FDA Biosciences Library and researchers assigned to all sites within the agency. The U.S. Food and Drug Administration request proposal responses from qualified sources capable of providing 24 hours a day, 7 days a week web access to Natural Medicines Comprehensive database or equal to product. BASE YEAR CLIN 0001- Online web access - Natural Medicines Comprehensive database (brand name or equal to), Period of Performance: 1 Year OPTION YEAR 1 CLIN 0002 - Online web access - Natural Medicines Comprehensive database (brand name or equal), Period of Performance: 1 YEAR OPTION YEAR 2 CLIN 0003 - Online web access - Natural Medicines Comprehensive database (brand name or equal), Period of Performace: 1 YEAR OPTION YEAR 3 CLIN 0004 - Online web access - Natural Medicines Comprehensive database(brand name or equal), Period of Performance: 1 YEAR Anticipated Base Year Period of Performance: January 1, 2010 – December 31, 2010 (plus 3 one year options) If not brand name as specified above, the proposed product shall meet the following Salient Characteristics: 1. The system shall support the FDA Biosciences Library and researchers assigned to all sites within the agency. 2. The contractor must provide the FDA Biosciences library a web search platform with unlimited searching for eight (8) concurrent users. 3. The system must provide unlimited web access to the Natural Medicines Comprehensive database or equal to product. 4. The system must include a core ingredient database containing detailed, evidence-based monographs on individual natural ingredients. This specific database must include safety information, scientific names, other common names, effectiveness ratings, mechanism of action, adverse reactions, interactions, dosage and administration, editor's comments, and references and research abstracts. 5. The system must incorporate a Brand Name Products database to allow for seamless searches for relevant information. 6. The database must include effectiveness ratings for products studied in clinical trials. 7. The system must contain the "Canadian Licensed Natural Health Products" and the "Herbal Fixed Combination Products" for FDA reference purposes. 8. The system must contain the "Clinical Management Series" and must contain special reports on topics of current interest. 9. The vendor must be available to provide customer/technical service via telephone and email during standard Eastern business hours. 10. This requirement is subject to Section 508 compliance. Vendor proposals shall address how the proposed solution will comply with Section 508. Evaluation Factors for Award: The Government shall award a contract resulting from this solicitation to the responsible offeror whose offer is the lowest price technically acceptable offer, which shall represent best value to the Government. Award will be made on the basis of the lowest evaluated price (inclusive of options) meeting or exceeding the non-cost factor (technical conformance to the requirements of the solicitation). The Government intends to evaluate offers and award a contract without discussions. The offeror's initial offer should contain the offeror's best terms from a price standpoint. However, the Government reserves the right to conduct discussions if later determined by the Contracting Officer to be necessary. The Government may reject any or all offers if such action is in the best interest of the Government; accept other than the lowest offer; and waive informalities and minor irregularities in offers received. Evaluation Factors for Award: Lowest price, Technically acceptable. Offerors shall price each CLIN (including options). This is an all or nothing requirement, therefore, vendor shall provide a price for each requirement with the CLINs, otherwise your proposal will be determined to be substantially incomplete and not warrant any further consideration. The following factors shall be used to evaluate offers: 1. Technical Features Meeting/Exceeding Salient Requirements (Brand Name or Equal) 2. Total Price (all CLINs shall be priced) Proposal Instructions to Offerors: Offerors are required to submit their proposals in two separate volumes as follows: Volume I – Technical Volume II – Pricing Proposal The completion and submission of the above items will constitute an offer (proposal) and will indicate the offeror’s unconditional assent to the terms and conditions of this RFP and any attachments hereto. Alternate proposals are not authorized. Objections to any terms and conditions of the RFP will constitute deficiency, which may render the offer unacceptable. Volume I – Technical: This volume shall contain the Technical Approach. This portion of the proposal to include all data and information required for technical evaluation of brand name or equal product, and exclude any reference to the pricing aspects of each offer. If an equal product is proposed, offeror shall demonstrate how that product is equal to the brand name product. Offerors shall demonstrate in sufficient detail a technical approach that will successfully accomplish each of the requirements of the salient characteristics. For purposes of clarification for the Technical Evaluation Team, offerors are encouraged to provide trial access to their products to demonstrate how the requirements of the attached SOW are addressed and met. Volume II – Pricing: This volume shall include the complete pricing. Offerors shall propose pricing for a one year base period with an option for three (3) additional 1 year periods. FAR Provisions & Clauses: FAR 52.203-6 ALT I, Restrictions on subcontractor Sales to the Government. FAR 52.211-6, Brand Name or Equal. FAR 52.212-1, Instructions to Offerors---Commercial Items, apply to this acquisition with the exception of (d), (h), and (i) of the clause, which are RESERVED; FAR 52.212-3, Offeror Representations and Certifications-Commercial Items FAR 52.212-4, Contract Terms and Conditions---Commercial Items; FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items. In compliance with said clause, the following FAR clauses apply: 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns; 52.222-3, Convict Labor; 52.222-19, Child Labor—Cooperation with Authorities and Remedies; 52.222-21, Prohibition of Segregated Facilities; 52.222-26, Equal Opportunity; 52.222-36, Affirmative Action for Handicapped Workers with disabilities; 52.225-13, Restrictions on Certain Foreign Purchases 52.232-33, Payment by Electronic Funds Transfer—Central Contractor Registration (Oct 2003) FAR 52.213-2, Invoices Offerors are reminded to include a completed copy of 52.212-3 ALT I with their response, or provide an affirmative response that the offeror is registered in ORCA and all information in ORCA is current and complete. All clauses shall be incorporated by reference or full text in the order. Additional contract terms and conditions applicable to this procurement: 52.217-9 Option to Extend the term of the Contract (MAR 2000) (a) The Government may extend the term of this contract by written notice to the Contractor within 30 days; provided, that the Government gives the Contractor a preliminary written notice of its intent to extend at least 60 days before the contract expires. The preliminary notice does not commit the Government to an extension. (b) If the Government exercises this option, the extended contract shall be considered to include this option clause. (c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed 48 months. (End of clause) The contractor is requested to hold price quotations for a minimum of 45 days. Other Administrative Instructions: Central Contractor Registration (CCR). In accordance with FAR 52.212-4, Offerors shall be registered in the CCR database to be considered for award. Registration is free and can be completed on-line at http://www.ccr.gov; provide DUNS number; Cage Code and TIN. Proposals shall be submitted by email only as a MS Word or Adobe PDF attachment to Brendan McCarthy at brendan.mccarthy@fda.hhs.gov. Proposals are due by 3:00 pm Eastern Time on 11 DEC 2009. Any questions must be addressed to Brendan McCarthy, brendan.mccarthy@fda.hhs.gov/301-827-4680.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-10-1067592/listing.html)
 

Place of Performance

Address: FDA Biosciences Library, WO2, Room 3051, 10903 New Hampshire Ave, Silver Spring, Maryland 20993, United States, Silver Spring, Maryland, 20993, United States

Zip Code: 20993
 

Record

SN02019684-W 20091211/091209234352-5840668ab1800dedfbe41daf098d0217 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |